Published in Gene Therapy Weekly, August 5th, 1996
The trial marks a transition from the exploration of gene therapy for patients with imminently fatal diseases such as cancer or AIDS to therapy for disabling, chronic disorders such as arthritis. It is the first such study for an autoimmune disorder. It is the first gene therapy protocol for a disorder of connective tissues, which bind together and support various structures of the body. A copy of the protocol was published in the June 20, 1996, issue of Human...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.